Relmada Therapeutics, Inc. RLMD Book value per share

Book value per share at other companies

Johnson & JohnsonJNJ

$34.82+7.3%

Aardvark Therapeutics, Inc.AARD

$3.99-65.1%

CG OncologyCGON

$11.67+32.7%

Nuvectis Pharma, Inc.NVCT

$0.61-42.2%

ImmunomeIMNM

$4.64+49.8%

Nuvation BioNUVB

$0.73-33.5%

FAQ

What is Relmada Therapeutics, Inc.'s book value per share?

Relmada Therapeutics, Inc. (RLMD) reported book value per share of $2.53 in Q1 2026.

How has Relmada Therapeutics, Inc.'s book value per share changed year-over-year?

Relmada Therapeutics, Inc.'s book value per share increased by 242.3% year-over-year, from $0.74 to $2.53.

What is the long-term trend for Relmada Therapeutics, Inc.'s book value per share?

Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s book value per share has grown at a -20.2% compound annual growth rate (CAGR), from $6.77 to $2.19.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.